• Connect with us at AMCP Nexus. 
• Register for the upcoming AMCP Webinar hosted by FormularyDecisions, “Harnessing the Power of AI in Health Evidence Generation Strategy.”
• SpringWorks Therapeutics Named 2024 Innovation & Impact Emerging Biopharma Winner - Watch the interview now. 
• Keep up on the latest developments with the AMCP Format v5.0 resources. 

Hold the date for our FormularyDecisions Biopharma Lunch & Learn session.

Date: Tuesday, October 15th
Time: 12-1pm PT
Registration link coming soon.

Click here to be notified of additional details.

Interested in connecting with our team at Nexus?

Click below to book a meeting with one of our experts:

Date: Tuesday, September 17, 2024  
Time: 2-3 PM ET 
Hosted by: FormularyDecisions 
 
Please join us for an interactive session exploring artificial intelligence (AI)’s applications and limitations in the realm of evidence generation strategies. In this session, we will review insights from healthcare decision makers on AI adoption within their organizations. Additionally, our expert panelists will explore opportunities to mitigate concerns about AI acceptance and hesitation in today’s complex landscape. Using real-world case studies, we will also share how AI can be used to improve efficiencies in aggregating data and communicating evidence.  

Who should attend? Team members across the biopharma industry, managed care professionals, as well as other new and seasoned learners from across the healthcare landscape can benefit from panelist insights and perspectives. Join us for an engaging discussion and unlock AI's capabilities and potential in accelerating innovation. Register today to secure your spot! 

Learning objectives: 

• Review market research insights on AI adoption and perceptions among healthcare decision makers. 
• Examine current capabilities and limitations of AI-powered tools. 
• Identify best practices for the practical application of AI in health evidence generation strategy. 
• Discuss trends and future opportunities to accelerate the trajectory of AI in an evolving landscape. 

Click below for webinar details and to register through the AMCP website: 

Date: Thursday, July 25, 2024 

In this session, we explore the key differences between newly approved agents, their place in therapy based on 2024 immunization recommendations, and best practices for discussing vaccines in diverse community pharmacy settings. Given that vaccination rates can be affected by many factors, including cultural, social, and political influences, the session will incorporate interactive case studies to also address opportunities for overcoming vaccine fatigue and hesitancy. 

Learning objectives:

• Summarize the clinical trial results and considerations for use of newly approved agents 
• Review 2024 immunization schedules and recommendations based on expert consensus guidelines 
• Review guidance for administration of vaccines 
• Apply strategies for discussing vaccines with patients in the pharmacy setting to improve overall community health outcomes 

The Cencora team has received many questions regarding the changes to the AMCP Format and how it will affect current and future dossiers. Our AMCP dossier experts are offering an informal 30-minute call to provide an overview of the key changes within AMCP Format v5.0 and answer any questions that you may have regarding this update.  

We are also able to share insights into opportunities for new evidence generation and product differentiation with the new Format v5.0.  

Interested in learning more? Connect with one of our dossier experts below: